Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Medical Studies (IMS) is a clinical research organization and site based in New Port Richey, Florida, specializing in Phase II through Phase IV clinical trials. Founded in 1991, the center provides comprehensive research services to the pharmaceutical and biotechnology industries, focusing on therapeutic areas such as neurology, internal medicine, and orthopedics. IMS is recognized for its expertise in conducting trials for chronic conditions, including Alzheimer’s disease, diabetes, and osteoarthritis. The facility is equipped with dedicated research staff and diagnostic capabilities to ensure high-quality data collection and patient safety. By bridging the gap between drug developers and patient populations, IMS plays a critical role in the clinical validation of new therapeutic interventions. The institute maintains a large patient database and has a long-standing reputation for excellence in the Tampa Bay area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Medical Studies.